| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $46,494,174 ) (Continued on the next page) |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS126282 | Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain Injury | 000 | 4 | NIH | 2/20/2026 | $728,961 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH116170 | Cerebellar Modulation of Cognition in Psychosis | 000 | 8 | NIH | 12/3/2025 | $827,269 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079864 | Brain Vulnerability in Delirium and Alzheimer’s Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation | 000 | 4 | NIH | 12/12/2025 | $741,776 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01NS102289 | StATins Use in intRacerebral hemorrhage patieNts (SATURN) | 000 | 6 | NIH | 4/7/2026 | $2,376,186 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01CA263986 | Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients | 000 | 5 | NIH | 5/7/2026 | $311,320 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RC2DK116691 | Investigating Human Adipocyte Heterogeneity | 001 | 9 | NIH | 5/6/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA271601 | Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments. | 000 | 4 | NIH | 4/6/2026 | $645,366 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS126282 | Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain Injury | 001 | 4 | NIH | 3/13/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA011576 | Alcohol and Monocyte Signaling | 000 | 23 | NIH | 4/2/2026 | $904,503 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R33CA309703 | Novel Monoclonal Antibody Tools for Exploring the Altered Glycocalyx in Tumor Cells | 000 | 1 | NIH | 3/13/2026 | $430,521 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA030770 | Cholesterol toxicity in alcohol-associated hepatitis | 000 | 4 | NIH | 4/27/2026 | $670,103 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23ES035863 | Climate Variability and Respiratory Health in Asthma and COPD | 000 | 3 | NIH | 4/1/2026 | $256,644 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK088826 | INF2 in kidney function and dysfunction | 000 | 14 | NIH | 4/13/2026 | $632,384 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI189475 | Phosphatases in lupus | 000 | 2 | NIH | 4/24/2026 | $558,045 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082016 | Wake-sleep Circuitry in Neurodegenerative Dementias | 000 | 3 | NIH | 4/13/2026 | $909,276 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079799 | Molecular mechanisms of aging and accelerated aging in the human brain | 000 | 3 | NIH | 3/20/2026 | $182,997 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI177687 | Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination | 000 | 4 | NIH | 4/27/2026 | $1,500,997 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK146795 | Adiponectin Signaling in Bladder Function | 000 | 1 | NIH | 4/24/2026 | $739,141 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171101 | Rechargeable Anti-thrombogenic Films for Blood Contacting Applications | 001 | 3 | NIH | 3/24/2026 | $23,100 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL164976 | Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes | 000 | 4 | NIH | 3/23/2026 | $191,484 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer’s disease | 001 | 4 | NIH | 4/10/2026 | $105,621 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AG085089 | A lab-on-a-chip device for measuring multiple biochemical and biophysical biomarkers of Alzheimer’s disease | 000 | 3 | NIH | 3/26/2026 | $216,125 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK128406 | The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation | 000 | 5 | NIH | 3/23/2026 | $514,655 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 001 | 3 | NIH | 3/24/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS115972 | Cortical-Meningeal Interactions Underlying Migraine Headache | 000 | 5 | NIH | 3/26/2026 | $466,814 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AT012166 | Mindful Steps: A Web-Based Mind-Body Exercise Intervention to Promote Physical Activity in Chronic Cardiopulmonary Disease | 000 | 3 | NIH | 5/4/2026 | $806,077 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL173557 | Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure | 001 | 3 | NIH | 4/23/2026 | $22,476 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL177076 | Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR | 002 | 2 | NIH | 4/21/2026 | $22,195 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21NS142800 | SourceSpikeNet – A Biophysically Grounded AI Approach to Spike Detection in EEG | 000 | 1 | NIH | 4/21/2026 | $252,060 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01EB025173 | Endoscopic Fine-Needle Light Scattering Spectroscopy for Pancreatic Cyst Diagnosis and Evaluation of Malignant Potential | 000 | 7 | NIH | 5/5/2026 | $627,331 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00EY032181 | Epigenomic mechanisms regulating RGC survival and axon regeneration | 000 | 6 | NIH | 5/5/2026 | $249,998 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171121 | Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | 001 | 3 | NIH | 4/23/2026 | $21,034 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL167383 | Thiol Isomerases and Oxidant Stress in Thrombus Formation | 000 | 3 | NIH | 4/21/2026 | $656,455 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MD016068 | Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts | 000 | 5 | NIH | 4/21/2026 | $831,518 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K38AG094915 | Improving integration of treatment burden information in primary care for older adults with multiple chronic conditions | 000 | 2 | NIH | 4/21/2026 | $107,330 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24AT009465 | Mentoring and Patient-Oriented Research in Integrative Medicine | 000 | 8 | NIH | 4/21/2026 | $139,701 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00AG065495 | Multifunctional tough adhesive hydrogels to recruit, expand, and deliver tendoncells during aging and injury | 000 | 5 | NIH | 1/21/2026 | $121,030 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 000 | 4 | NIH | 1/22/2026 | $640,361 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL177076 | Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR | 001 | 2 | NIH | 3/6/2026 | $702,834 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS139479 | Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment Outcomes | 000 | 2 | NIH | 3/19/2026 | $679,625 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA262629 | Personalized Adoptive T-cell Therapy for AML | 000 | 5 | NIH | 3/19/2026 | $728,501 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA257672 | Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy | 001 | 4 | NIH | 4/16/2026 | $71,150 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA285395 | Resolution of inflammation in chemical-induced cancer | 001 | 2 | NIH | 4/16/2026 | $71,526 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 000 | 5 | NIH | 4/17/2026 | $10,000 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 000 | 5 | NIH | 4/17/2026 | $140,642 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 001 | 5 | NIH | 4/16/2026 | $56,402 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | DP1DA063166 | HIV vaccine swarms for PWID | 000 | 2 | NIH | 3/19/2026 | $1,210,300 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 001 | 5 | NIH | 3/18/2026 | $37,518 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer’s disease | 000 | 4 | NIH | 3/19/2026 | $712,409 |
|
